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Transesophageal echocardiography offers a noninvasive technique for the con-
tinuous monitoring ofcardiac performance. The combination of 2-dimensional
echocardiography and Doppler velocitometry provide assessment of cardiac
anatomy, valve function and, ventricular loading conditions. Although trans-
esophageal echocardiography has become accepted for perioperative monitor-
ing, it is typically used in conjunction with Swan-Ganz catheterization. To sup-
plant Swan-Ganz catheters, an echocardiographic technique to monitor cardiac
output is necessary. Despite considerable effort to achieve this goal, a satisfac-
tory technique has been difficult to realize. This paper discusses therole ofcar-
diac output monitoring in perioperative care and critically examines echocar-
diographic techniques for cardiac output monitoring.
Swan-Ganz (S-G)b catheterization provides a sophisticated assessment of cardiac
performance notpreviously attainable in the clinical setting. Measurements of ventricular
preload, mixed venous oxygen content, and CO have proven useful for diagnosis and to
guide therapy. Although noninvasive monitoring modalities have experienced startling
growth over the past decade, S-G catheters remain widely used in the operating room and
in critical care settings.
Despite the utility of S-G catheter monitoring, the invasive nature of the technique,
as well as recent concerns of the validity ofderived measurements, has fostered dissatis-
faction with the technique [1]. Owing to the inherent hazards, the technique requires
trained personnel, is expensive, and thus can bejustified in only a select group ofcritic-
ally ill patients. The validity of measurements derived from S-G catheter data in many
settings has been questioned. Two-dimensional echocardiographic (2-D echo) studies
have shown pulmonary capillary wedge pressure to be an inaccurate guide to left ventric-
ular preload [2, 3, 4, 5]. As for monitoring myocardial ischemia, van Daele et al. [6]
among others have shown that S-G catheter-based indicators, such as acute increases in
pulmonary artery wedge pressures, are neither sensitive nor specific. Swan-Ganz mea-
sures of CO using the thermodilution technique have an established variability of 10 to
20% and can provide only intermittent assessment of cardiac function [7]. The recent
appreciation of these shortcomings has pushed development of alternative approaches to
cardiac assessment. While diverse techniques, which include transthoracic bioimpedance,
arterial pulse contour, and electrocardiographic R-T ratios, have been examined, it is
echocardiography which appears best suited to supplant the method ofSwan and Ganz.
Echocardiography can provide noninvasive assessment of cardiac anatomy, valve
function, ventricular preload, and blood flow. This has led to extensive use of the tech-
nique by cardiologists. Advances in instrumentation have enabled the development of
esophageal probes, which contain both 2-D echo and Doppler capabilities.
Transesophageal echocardiography has become accepted for monitoring cardiac function
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in the operating room, usually in conjunction with S-G catheters. To replace S-G catheter
monitoring, however, an echocardiographic technique to monitor CO is necessary.
Despite considerable effort towards this goal, it has been difficult to realize. This paper
will briefly discuss the need for direct measures ofCO in perioperative care and examine
the various echocardiographic approaches to noninvasive CO monitoring.
THE CASE FOR CO MONITORING
The importance of determination of CO to manage hemodynamic status is well
recognized. Cardiac output reflects upon the heart's performance as a pulsatile pump as
modified by vascular tone. Tissue oxygen delivery is the productofCO andarterial blood
oxygen content. The clinical utility of CO monitoring is well established. Even experi-
enced clinicians have difficulty in assessing CO. Connors et al. [8] showed that in an
intensive care setting a physician's clinical judgement is inadequate to differentiate
between high and low CO states. Eisenberg et al. [9] confirmed these results and found
that, in the majority ofpatients, planned therapy was altered by the information obtained
from S-G catheterization (Figure 1).
Additional studies have examined the role ofCO output monitoring to aid diagnosis
and guide therapeutic interventions. A study ofvascular surgery patients showed that pre-
operative maximization ofcardiac performance through CO monitoring resulted in signif-
icant reductions in postoperative cardiac complications [10]. Rao et al. [11] established
that sophisticated cardiac assessment, including CO monitoring, was valuable in the man-
agement of surgical patients who had suffered a recent myocardial infarction. Their data
shows such monitoring to reduce the incidence, morbidity, and mortality rate ofperioper-
ative reinfarction. When optimization of CO and oxygen delivery was set as the thera-
peutic goal, a prospective study demonstrated that outcome improved in critically ill
patients [12]. Thus, development of a continuous, noninvasive technique for assessment
ofCO would be ofconsiderableclinical significance.
PRINCIPLES OF DOPPLER ULTRASOUND
Ultrasound has rapidly advanced to the forefront ofdiagnostic imaging. It is capable
ofboth real timeimaging ofcardiac structures andmeasuring blood flow within the heart
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Figure 1. Discrepancies between a clinician's prediction of CO and that measured by
thermodilution.
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and great vessels. Consisting ofhigh frequency sound waves, ultrasound easily penetrates
skin and other body tissues, making it suitable for noninvasive applications. A fraction of
an emitted ultrasound signal is reflected as it encounters tissues ofdiffering acoustic den-
sity. The frequency, time delay, and amplitude of the ultrasonic backscatter or "echoes"
can be interpreted to create a 2-D image of the tissue or, using Doppler techniques, can
estimate blood flow velocity.
Clinical devices use sound wave frequencies of 1 to 10 million Hz to achieve an axi-
al resolution ofless than one millimeter. A tradeoffbetween tissue penetration and imag-
ing resolution dictates choice ofsignal frequency. High frequency signals provide superi-
or image resolution but penetrate only short distances. For example, a 5 MHz signal pro-
vides an axial resolution of0.5 mm but is limited to distances of 30 cm. When the power
emission is kept below 100 mWatts/cm, ultrasound has not demonstrated any injurious
effects and is approved for fetal imaging [13].
Blood flow velocity measurements using ultrasound arebased on the Dopplerprinci-
ple. When ultrasound is reflected from a stationary object, the reflected signal is of the
same frequency as that transmitted. Objects moving towards the transmitted signal cause
reflections of higher frequency. This alteration in frequency, the Doppler shift, is
described by the equation:
AF=2f,v Coso
s
where AF = Doppler shift,ft = transmitted frequency, v = velocity, s = speed of ultra-
sound in tissue, 0 = the angle ofincidence between the ultrasound beam and the direction
of the object's motion. The equation can berearranged to solve for velocity:
V2AF
ftcoso
Thus, the velocity of an object is related to two variables, the Doppler frequency
shift and the angle ofincidence between the direction ofthe object's motion and the trans-
mitted ultrasound signal (Figure 2).
The measurement of blood flow with Doppler ultrasound takes advantage of the
large ultrasound reflections caused by red blood cells. The Doppler shift from these
reflections can be used to quantitate blood flow velocity. To determine volumetric flow
(L/min-1), however, these velocities are multiplied by the cross-sectional area (CSA) of
the flow channel, that is:
F Flow = (CSA) J vdt
The accuracy of the Doppler technique is related to both velocity and area measure-
ments.
Transducer, ft \
Af c
Cos 0 2ft
Figure 2. Doppler technique for determination of flow velocity.
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DOPPLER INSTRUMENTATION
The technique for Doppler CO measurement requires an ultrasound transducer to
transmit and receive the ultrasound signal and a computer to convert the Doppler fre-
quency shift to flow velocities and CO. Piezoelectric crystals which mechanically oscil-
late when a voltage is applied generate the ultrasound signal. Conversely, when a reflect-
ed ultrasound signal impacts upon these crystals, an electric potential is generated. Two
types ofDoppler transducers, continuous wave andpulsed wave, arewidelyemployed for
cardiac monitoring. Continuous wave Doppler instruments employ two crystals, one
which continuously transmits an ultrasound signal and the other which acts as a receiver
for reflected signals. The pulsed-wave system employs a single crystal, which acts as
both the ultrasound transmitter and receiver. The crystal emits short bursts of ultrasound
at regular intervals and pauses between bursts to receive the reflected signal (Figure 3.).
The frequency ofthe pulsed ultrasound emissions is called the pulse repetition frequency.
As the speed of ultrasound propagation through tissue is fairly constant (1540 cm/sec),
Ar L
Figure 3a. Continuous wave Doppler transducer.
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Figure 3b. Pulsed wave Doppler transducer.
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the delay between transmission andreception ofthe reflected signal is dictatedby the dis-
tance of the reflector from the transducer. By regulating the waiting period from signal
transmission to reception, the pulsed wave transducer can select the exact distance from
which the reflected signals originated. This capacity, called "range gating", allows the
operator to sample blood flow from a specific location in a cardiac chamber or major
blood vessel and is a major advantage to pulsed-wave Doppler. The disadvantage of this
approach is that the pulsed technique limits the maximum velocities that can be measured
to one half the pulse repetition frequency. This maximum frequency shift is known as the
Nyquist limit. At frequencies above the Nyquist limit the returning signal becomes dis-
torted ("aliasing"), making the velocity indeterminable. As the depth of the sample vol-
ume increases so does the pulse repetition frequency and, thus, the maximum velocities
which can be measured becomes limited. A comparison ofthe advantages ofpulsed wave
versus continuous wave Doppler measurement techniques ispresented in Table 1.
Both pulsed wave and continuous wave Doppler can be used in conjunction with 2-D
echo so that the Doppler signal can be directedprecisely (Figure4). This allows the oper-
ator to place the beam parallel to blood flow, and, with the pulsed wave technique, per-
mits the selection of a sample volume within the aorta or valve orifice.
SOURCES OF ERROR IN DOPPLER CO DETERMINATION
Although the Doppler approach is theoretically sound and has been validated in
experimental flow systems, several potential sources of error become apparent when the
technique is applied to the clinical setting [14, 15]. Inaccuracies in the measurement of
velocity and CSA can result in erroneous flow measurements.
Errors with cross sectional area determination. Determination of cross sectional
area is most commonly derived from equations based on measurements ofvalve or vessel
diameter. This requires an assumption of the geometric shape of the flow chamber. For
the aortic and pulmonary valve area measurements, the use of a circular nr2 model
appears acceptable. However, the geometry of the mitral and tricuspid valves would be
best modeled as an ellipsoid and, thus, require orthogonal 2-D echo images for CSA esti-
mation. In circular or ellipsoid models, accuracy in diameter measurements are critical
because CSA is an exponential product of diameter. For example, a 2 mm error in mea-
surement of a 25 mm aorta results in a 17% error in CSA. To obviate the need for an
echocardiographic measurement of aortic CSA, some devices employ a nomogram to
estimate aortic CSA based on the patient's height, weight, and age. While such nomo-
grams may correlate well in large population studies, they may be invalid for any given
patient.
The second weakness of using fixed diameter measurements for calculating CSA is
that the method does not account for variations in vessel size during the cardiac cycle and
with changes in pressure. This would be a only a minor source of error for aortic mea-
Continuous- Pulsed-
Feature Wave Wave
Quantitatively Measure Yes No
High Velocities
Select Specific Sample Volume No Yes
Use in Combination Yes Yes
with 2-D Imaging
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Figure 4. 2-D echo used to position the sampling volume of a pulsed wave Doppler signal at
the mitral valve annulus. Derivedvelocity tracings are shown below.
surements, where the systolic variation is small but can be significant for measurements
of the pulmonary artery and mitral valve. The large variations in pulmonary artery size
(up to 20%) during systole may account for the poor correlations of Doppler CO mea-
surements at this site [16].
An alternative approach to CSA estimation is to use 2-D echo along a short axis
plane. The utility of this approach is hampered by the technical difficulty in obtaining a
short axis view and errors related to the imprecision ofplane positioning. Also, a short
axis view lies perpendicular to the plane required for optimal Doppler measurements.
Recent advances in transducer technology have resulted in biplane and multiplane trans-
esophageal transducers which may permit more precise beam orientation and greater
accuracy in CSA estimation.
Errors in velocity determination. Continuous wave Doppler measurements esti-
mate velocities along the entire path of the ultrasound beam, and require the assumption
that the maximal velocities registered equate with the mean blood velocity at the site of
CSA estimation. With pulsed wave systems, the velocities can beprecisely sampled atthe
site of CSA determination. Both techniques, however, rely on sample sizes that are a
small fraction ofthe total CSA (typically less than 10%) and, therefore, requireextrapola-
tion of the measured velocity to calculate mean flow velocity for the vessel. Such an
t.:.I,/ it t V
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Figure 5. Blood flow velocity prorile in the aorta. The blunt profile resulting from the accelera-
tion ofblood in the leftventricular outflow tractbecomesparabolic and asymmetric in aortic arch.
extrapolation assumes thatblood flow velocities areequal across the vessel, i.e., a "blunt"
flow profile. A blunt profile in the left ventricular outflow tract and across the semilunar
valves results from the acceleration and convergence ofblood flow. Turbulent flow, seen
in conditions of aortic valvular disease and high output states, disrupts the velocity pro-
file. Alterations in the vessel geometry, such as curvature ofthe ascending aorta or asym-
metry of the outflow tract, will also cause deviations from a blunt profile and erroneous
Doppler measurements (Figure 5).
SITES FOR DOPPLER CO MONITORING
Aorticflow estimates ofCO. Most work on determination ofCO with Doppler ultra-
sound has focused on aortic velocity measurements. This approach is appealing, in that
many ofthe conditions required for accurate Doppler measurements are present. The aor-
ta is a concentric, low compliance structure. Additionally, blood flow in the left ventricu-
laroutflow tractandproximal aortahasbeen shown to have ablunt flowpattern [17, 18].
Doppler signals derived from ascending aortic flow can be reliably obtained from a
transcutaneous Doppler probe placed at the suprasternal notch (Figure 6). When com-
bined with a 2-D echo measurement of aortic diameter, CO can be calculated. This
approach has been validated by several investigators. However, manipulations required to
obtain adequate signals are time consuming and the technique provides only intennittent
measurements. These limitations have led to the development of alternative techniques
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Figure 6. Schematic ofthe suprasternal window to ascending aortic flow.
U''
Figure 7.Technique for transesophageal monitoring ofdescending aortic flow.
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which are better suited to monitoring purposes.
Transesophageal echocardiography employs an ultrasound transducer mounted on
the tip ofa steerable esophageal probe. The heart lies anterior to the esophagus and, thus,
the transesophageal approach avoids interference from ribs and lung tissue which ham-
pers transthoracic imaging. The closeproximity ofthe esophagus to thecardiac structures
enables high resolution images to be obtained. An acoustic window for imaging the
descending aorta can be reliably obtained bypositioning the probe to a depth ofapproxi-
mately 30 cm (Figure 7). With the transesophageal approach, the esophagus stabilizes the
probe position allowing continuous monitoring. Moreover, obtaining optimal Doppler
signals requires only rotation oftheprobe andadjustments in thedepth ofinsertion.
Determination of transesophageal Doppler estimates of CO using descending aortic
flow measurements requires a three step process. First, aortic CSA is estimated by nomo-
gram or a 2-D echo measurement. Second, the esophageal probe is positioned so as to
maximize descending aortic flow signals. Third, the descending aortic flow signals are
calibrated against a measure ofascending aortic flow. Such a calibration is necessary to
account for blood flow distributed to the head and upper extremities and for the signifi-
cant angle ofincidence between the Doppler signal and descending aortic flow. The cali-
bration procedure determines the proportionality constant, K-factor, which is the ratio of
ascending aortic to descending aortic flow. Once calibrated, the transesophageal Doppler
signals continuously monitorCObased on descending aortic flow.
Non-imaging transesophageal Doppler devices became commercially available in the
1980's. Miniaturization of the transducer allowed for an esophageal probe of 12 FR in
diameter including a port for stethoscopy. As anesthesiologists routinelyplace esophageal
stethoscopes for monitoring cardiorespiratory function during general anesthesia, trans-
esophageal CO monitoring does notrequire additional procedures to thepatient.
In clinical trials, transesophageal Doppler measurements have given inconsistent
results. Initial studies by Mark et al. [19] in patients undergoing aortocoronary bypass
surgery, found a poor correlation between Doppler and thermodilution measurements (r =
0.43). Their data showed that calibration ofthe esophageal probe was the major source of
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Figure 8. A second generation transesophageal Doppler device (Accucom 2) shows significant
improvement in performance as compared to prior technology.
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error. Freund [20] reported variable performance in acomparison ofDoppler to thermodi-
lution CO in 23 surgical patients. The authors concluded that the operator-dependent
nature of the Doppler technique contributed to the inconsistent results. Spahn et al. [21]
studied 35 patients and judged that the variability between Doppler and thermodilution
measurements (S.E. 1.4 L/min) was unacceptable forclinical monitoring.
Advances in Doppler technology have produced devices which have demonstrated
significant improvement in clinical trials. In an intraoperative evaluation of non-cardiac
surgery patients, Perrino et al. [22] reported thatreal-time display ofthe Doppler velocity
wave form and wide-beam esophageal transducers resulted in a marked reduction in the
measurement error of the Doppler technique (Figure 8). The improved accuracy of the
new generation Doppler devices has been confirmed by Schmid [23].
A source oferror specific to the transesophageal approach to determination ofCO is
the use ofthe proportionality constant or K-factor. The K-factor is determined during the
initial calibration procedure and is usually not adjusted during the operation. Several
studies have suggested that the K-factor can fluctuate during surgery as a response to
changes in sympathetic tone, arterial blood pressure, and alterations in anesthetic depth
[24, 25, 26, 27].
Recently, a transesophageal approach has been described for measurement ofascend-
ing aortic flow. This technique uses transesophageal echocardiography to obtain an apical
long axis view of the left ventricle and proximal aorta. This view is achieved by
Figure 9. Transesophageal echo probe positioned to interrogate ascending aortic flow.
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Figure 10. With the ultrasound transducer mounted at the tip of an endotracheal tube,
transtracheal Doppler monitors ascending aortic flow.
anteroflexion of the probe after it is positioned in the stomach (Figure 9). After 2-D echo
measurement ofaortic diameter, a pulsed wave sample volume is placed across the aortic
valve using 2-D echo guidance. Katz and colleagues [28] reliably obtained aortic flow
signals with this approach and derived CO measurements which correlated with thermod-
ilution measurement. In light of the simplification this technique promises, further evalu-
ation ofthe approach is warranted.
Transtracheal Doppler is a novel approach for monitoring ascending aortic flow. This
technique employs a non-imaging pulsed-wave Doppler crystal mounted to the tip of an
endotracheal tube. Positioning at the mid-trachea provides an acoustic window to the
ascending aorta (Figure 10). The transtracheal approach has several potential advantages
for CO monitoring. By incorporating the Doppler crystal into the endotracheal tube, no
additional procedures are required. As opposed to the transesophageal approach, no cali-
bration is needed as ascending aortic flow is directly monitored. Also, the pulsed wave
signal is used not only to determine blood flow velocity measurements but also to deter-
mine the diameterofthe flow channel. Thus, an independent echocardiographic measure-
mentofaortic dimensions is unnecessary when using this technique.
Initial work by Abrams et al. [29] showed that transtracheal Doppler CO measure-
ments were highly correlated with thermodilution measurements. Perrino et al. [30], in a
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prospective evaluation of the technique in 27 patients undergoing noncardiac surgery,
also demonstrated a good correlation with thermodilution measurement (r = 0.80) and
found that transtrachional Doppler measurements tracked sequential changes in CO with
precision. Transtrachional Doppler performance was found to be dependent on operator
experience and the stability of the received Doppler signal. A limitation to the transtra-
cheal approach is that patient positioning and the surgical manipulations associated with
open heart surgery significantly increase the error of the technique [31]. Further develop-
ment ofthis innovativeapproach may yield a satisfactory device forclinical use.
Transmitral and transpulmonicflow estimates ofCO. Transmitral flow measurement
has also been examined as a method for CO determination. Cineangiographic studies by
Lynch and Bove [32] showed a flat flow profile at the opening of the mitral valve. Cross
sectional area measurement is complicated by the ellipsoid shape of left ventricular
inflow tract and the significantvariations in mitral valve areaduringdiastole. Fisheretal.
[33] described a quantitative technique for CO determination using transmitral flow mea-
surements in an animal model. The flow velocity was sampled at the tips of the mitral
valve leaflets and the maximal opening area ofthe mitral valve seen on a 2-D echo short
axis image was corrected for diastolic variations in dimensions M-mode tracings of the
leaflets. They accurately estimated CO by this method. Stewart et al. [34] confirmed the
need fordynamic assessmentofmitral valve area in an experimental preparation. Clinical
validation of this approach has followed but difficulties in obtaining a clean, short axis
image ofthe thin pliable mitral leaflets limitits usefulness [35].
The shortcomings of the Fisher method have led to the search for a simplified tech-
nique. Meijboom et al. [36] reported a technique based on 2-D echo and Doppler mea-
surements from a single four-chamber view. Their data in both dogs and children showed
this method to be on par with the more complex method ofFisher. Holt [37] described a
technique using the apical four chamber view where M-mode tracings ofthe mitral valve
tips were used to estimate the mean mitral valve orifice area. They showed that these esti-
mates closely correlated to 2-D echo measures of mitral valve area and that Doppler CO
using this approach accurately estimates thermodilution CO. The above studies confirm
the validity ofthe transmittal approach and, by relying on a single imaging plane, greatly
simplify the technique.
The success of single plane mitral flow estimates of CO obtained by transthoracic
Doppler has led to its application via transesophageal echocardiography. An initial report
by LaMantia et al. [38] found a strong correlation between DopplerderivedCO measured
at the mitral valve leaflets and thermodilution. Ryan et al. [39] also found trans-
esophageal Doppler measurements of mitral flow to provide accurate determination of
CO. Other reports have not been as encouraging. Muhiudeen et al. [40], in an intraopera-
tive study oftransesophageal Doppler, measured mitral CSAat the annulus and velocities
from the leaflet tips. Poor correlations with thermodilution were obtained. Further, the
error could not be attributed solely to errors in CSA estimation. Shimamoto et al. [41]
using both area and velocity measurements obtained at the level of the annulus, also
found poor agreement between Doppler and thermodilution CO measurements. Clearly,
the utility ofmitral flow measurements ofCO, as determined by transesophageal Doppler
estimations, is not resolved. Accurate measurements appear to require a dynamic assess-
ment of the mitral orifice throughout diastole. The recent development of multiplane
echocardiography may also offer improvements in the accuracy of both flow and area
measurements.
Doppler measurements of PA blood flow are complicated by systolic variations in
vessel CSA and technical imaging difficulties. The transesophageal probe must be ante-
flexed at the basal short axis view to obtain pulmonary artery measurements. Muhiudeen
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et al. [40] reported that they were unable to obtain either adequate 2-D echocardiography
or Doppler signals of the pulmonary artery in 20 of 140 measurements (14%). They
found only a modest correlation between Doppler and thermodilution-determined CO
estimates (r = 0.65). Further, sequential changes in Doppler-defined CO were in the oppo-
site direction to changes in thermodilution measurements in 20 of65 events (31%). More
recently, Savino et al. [42] used transesophageal echocardiography to determine CO in 33
cardiac surgery patients. They found pulmonary artery Doppler-defmed estimates to be
highly correlated with thermodilution measurements, although they were unable to obtain
adequate signals in 24% ofpatients. This study supports the view that, with careful tech-
nique and proper selection of area and velocity measurements, accurate estimates of CO
are feasible using dataobtained from the pulmonary artery. Its utility forclinical monitor-
ing, however, remains in doubt.
CONCENTRIC BEAM DOPPLER
The clinical application ofDoppler instrumentation for CO monitoring has been hin-
dered by errors introduced by the unknown angle of incidence between the ultrasound
beam and blood flow. This error is important as it effects both CSA and velocity mea-
surements. Use ofconcentric beam Doppler measurements represents a novel approach to
reducing such errors.
The concentric beam Doppler measurement technique consists of a non-imaging
pulsed-wave Doppler system which is capable of transmitting and receiving two parallel
channel ultrasound beams (Figure 11). One of the Doppler emissions consists of a wide .t
I Pw (Power from wide beam)
Pn (Power from narrow beam)
Fd (mean Doppler frequency)
Figure 11. Concentric beam Doppler utilizes Information from both a wide and a narrow
ultrasonic beam for CO determination.
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ultrasound beam (30 mm diameter). This technique thus allows complete interrogation of
the ascending aorta. The second, or narrow beam, has a small sample volume within the
core ofaortic flow. The details ofthe measurement technique are as follows: Mean aortic
blood velocity is determined from the wide beam. The width of this beam allows mea-
surement ofthe mean velocity ofall blood passing through the aorta. Thus, errors associ-
ated with extrapolation from a small sample volume of aortic flow are avoided and a
blunt flow profile does nothave tobe assumed.
The CSA ofthe aorta is determined from the intensity (power return) ofthe received
Doppler signals from the two beams. The intensity ofthe each received Doppler signal is
proportional to the number of red blood cells within the beams path. The power of the
wide beam (Pw) equals the projected aortic area (Ap) multiplied by an attenuation con-
stant (Ka) as follows:
Pw = Ap Ka
The true CSA of the aortic flow channel is the projected area divided by cos 0. The pow-
er return from the narrow beam is equal to the known area of this beam (An) multiplied
by the same attenuation constant. Therefore, the true CSA of aortic flow can be deter-
minedby theratio ofthepowerreturns from the twobeams, as follows:
A = An cosO PW
Pn
Thus, aortic CSA can be determined solely from the Doppler measurements. This
obviates the need for 2-D echo instrumentation. Further, estimates are dynamic assess-
ments ofthe flow channel rather than theanatomic CSA.
Calculation of CO is the product of the velocity and CSA measurements and heart
rate:
CO= D-A An p HR coso Hn
where D is a precalibrated attenuation constant. Because the cosine function cancels out
ofthe equation, the technique isangle independent, amajoradvantage.
Initial reports by Taylor and Silke [43] in cardiac catheterization patients and by
Looyenga et al. [44] in patients in intensive care units showed the concentric beam
Doppler device measurements to correlate well with thermodilution measurements. In
contrast, subsequent reports have notbeen favorable, with standard error ofthe estimates
of approximately 1.5 L/min-I [45, 46, 47]. These errors are clearly unacceptable for a
clinical monitor and are larger than those obtained with conventional Doppler measure-
ment devices. The varied results from use ofthe concentric beam Doppler tecnhique can
be attributed to both theoretical and practical considerations. In the clinical setting, the
operator cannot be assured that the wide beam encompasses the entire aortic flow chan-
nel. The diameter of the beam used in the above studies was 30 mm which approximates
the diameter of a normal aorta. However, eccentric placement of the ultrasound beam
would lead to incomplete interrogation ofaortic flow and, thus, underestimation ofCSA.
Secondly, the operator cannot be assured that the narrow beam will remain focused at the
depth appropriate for aortic flow velocity measurements. This could result in additional
inaccuracies in the CSA measurement Further, most authors have noted technical diffi-
culties in properly positioning the concentric beam device using the suprasternal
approach [43,45]. Taylor and Silke [43] note that proper aiming ofthe transducer is criti-
cal for reliable performance and these authors recommend thatperformance of 100 exam-
inations is needed for an operator to become proficient with its use. Niclou et al. [451,
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however, did not find improvement with experienced operators. Refmements in the oper-
ational features of concentric beam devices appear warranted and may resolve the diffi-
culties with probepositioning.
CONCLUSION
Transesophageal echocardiography is uniquely suited to provide continuous, nonin-
vasive assessment of cardiac function. The combination of 2-D echo imaging with
Doppler ultrasonography has proven useful in theperioperative period for monitoring left
ventricular preload, myocardial ischemia and valvular function. An echocardiographic
technique for monitoring CO, however, has been more difficult to realize. Although the
soundness of the Doppler technique has been validated, it is in the clinical application
where substantial measurement errors have been found to occur. Precise measurement
technique is required to avoid errors in both area and velocity measurements. Rapid
advances in transducer technology and electronics, including multiplane transducers,
automated border detection and concentric beam Doppler, promise further improvements
to the technique. Until such improvements are realized, the thermodilution technique
remains the standard forperioperative CO monitoring.
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